Atripla (tenofovir disoproxil fumarate, emtricitabine and efavirenz) is now contraindicated with St John’s wort.
Nitro-Dur (glyceryl trinitrate) is now contraindicated in patients taking the soluble guanylate cyclase stimulator riociguat for chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension, as concomitant use can cause hypotension.
Sensipar (cinacalcet hydrochloride) treatment should not be initiated in patients with chronic kidney disease receiving dialysis if serum calcium is less than 8.4 mg/dL (2.1 mmol/L) due to the risk of hypocalcaemia.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629